The beat on EPS and raised full-year guidance indicate sustained operational leverage. With gross margins expanding and international momentum strong (EMEA +20%, APAC +18%), watch for further upside to estimates. The stock should react positively in the near term.
Price Chart
Executive Summary
LeMaitre Vascular reported Q1 2026 EPS of $0.68 (+42% YoY), a 3% beat on consensus of $0.66, on revenue of $66.6M (+11% YoY, in line with $66.7M consensus). The company raised full-year 2026 guidance: operating income midpoint increased to $79.8M (from $77.8M) and EPS to $3.00 (from $2.91), implying 24% adjusted EPS growth. Gross margin expanded 350 bps to 72.7%, and all product lines and geographies posted record sales.
Key Financial Metrics
Key Facts
- Q1 2026 EPS $0.68 beat consensus ($0.66) by 3.0%
- Q1 sales $66.6M (+11% YoY, +10% organic), in line with guidance midpoint
- Gross margin 72.7% (+350 bps YoY); operating margin 27% (+570 bps)
- Full-year 2026 guidance raised: revenue $277M–$283M (midpoint $280M, +12%), EPS $2.93–$3.08 (midpoint $3.00, +19%/+26% adjusted)
- Artegraft grew 36% worldwide; all three geographies posted record sales
Financial Impact
EPS beat of $0.02 vs consensus; guidance raised by $0.09 at midpoint
Risk Factors
- Revenue slightly below consensus by ~$0.15M (0.2% miss) may be noted by some
- Currency headwinds impacted reported sales by ~$2M in Q1
- Guidance assumes no further macroeconomic deterioration
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-206578 |
| Document: d94324d8k.htm | 0001193125-26-206578 |
| Document: 0001193125-26-206578-index-headers.html | 0001193125-26-206578 |
| Document: 0001193125-26-206578-index.html | 0001193125-26-206578 |
| Document: 0001193125-26-206578.txt | 0001193125-26-206578 |
| 8-K Data (Synthetic) | 0001193125-26-206578 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 27, 2026 5w ago | Press Release | $80.45 $82.34 | ▲ +2.35% | ▲ +2.09% | $78.78 (−2.08%) |
Jul 14, 2026 11w ago | Press Release | $99.79 $82.13 | ▲ +17.70% | ▲ +20.04% | $78.78 (+21.06%) |
May 7, 2026 21w ago | Insider Cluster | $107.91 $91.64 | ▲ +15.08% | ▲ +18.21% | $78.78 (+27.00%) |
May 7, 2026 21w ago | Insider Cluster | $107.91 $91.64 | ▼ −15.08% | ▼ −18.21% | $78.78 (−27.00%) |
May 7, 2026 21w ago | Insider Cluster | $107.91 $91.64 | ▼ −15.08% | ▼ −18.21% | $78.78 (−27.00%) |
May 5, 2026 21w ago | 8-K | $110.22 $91.64 | ▼ −16.86% | ▼ −19.64% | $78.78 (−28.53%) |
Apr 14, 2026 24w ago | DEFA14A | $117.39 $101.64 | ▼ −13.42% | ▼ −19.71% | $78.78 (−32.89%) |
Apr 14, 2026 24w ago | 8-K | $117.39 $101.64 | ▼ −13.42% | ▼ −19.71% | $78.78 (−32.89%) |
Mar 11, 2026 29w ago | Insider Cluster | $108.09 $112.71 | ▲ +4.27% | ▲ +3.75% | $78.78 (−27.12%) |
Feb 26, 2026 31w ago | Insider Cluster | $113.43 $110.33 | ▲ +2.73% | ▼ −3.67% | $78.78 (+30.55%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access